Safe time limits of aortic cross-clamping and cardiopulmonary bypass in adult cardiac surgery

Perfusion

Volumn 24, Issue 5, 2009, Pages 297-305

  Nissinen, Juha ^a   Biancari, Fausto ^b   Wistbacka, Jan Ola ^a   Peltola, Timo ^a   Loponen, Pertti ^c   Tarkiainen, Pekka ^a   Virkkilä, Markku ^a   Tarkka, Matti ^c  

^a VAASA CENTRAL HOSPITAL   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

aortic cross clamping; cardiopulmonary bypass; duration; perfusion; safe limit

Indexed keywords

ADULT; AGED; AORTA; ARTICLE; CARDIOPULMONARY BYPASS; FEMALE; HEART SURGERY; HUMAN; MALE; METHODOLOGY; PREDICTION AND FORECASTING; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SAFETY; SURVIVAL RATE; TIME; TREATMENT OUTCOME;

ADULT; AGED; AORTA; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SAFETY; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950349097     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659109354656     Document Type: Article

References (14)

1. Guru V., Omura J., Alghamdi AA, Weisel R., Fremes SE Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation 2006; 114(1 suppl): 1331-1338.
2. Jacob S., Kallikourdis A., Sellke F., Dunning J. Is blood cardioplegia superior to crystalloid cardioplegia? Interact Cardiovasc Thorac Surg 2008; 7: 491-499.
3. Biancari F., Rimpiläinen R. Meta-analysis of randomized trials comparing the effectiveness of miniaturized versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart (in press).
4. Khabar KS, elBarbary MA, Khouqeer F., Devol E., al-Gain S., al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/ multiple organ dysfunction syndromes. Clin Immunol Immunopathol 1997; 85: 97-103.
5. Whitten CW, Hill GE, Ivy R., Greilich PE, Lipton JM Does the duration of cardiopulmonary bypasss and aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg 1998; 86: 28-33.
6. Kang N., Cole T., Tsang V., Elliott M., de Leval M. Risk stratification in paediatric open-heart surgery. Eur J Cardiothorac Surg 2004; 26: 3-11.
7. Salis S., Mazzanti VV, Merli G., et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth 2008; 22: 814-822.
8. Nashef SA, Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999; 16: 9-13.
9. Roques F., Michel P., Goldstone AR, Nashef SA The logistic EuroSCORE. Eur Heart J 2003; 24: 881-882.
10. Levey AS, Greene T., Kusek J., Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
11. Paparella D., Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21: 232-244.
12. Onorati F., De Feo M., Mastroroberto P., et al. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg 2005 ; 79: 837-845.
13. Bucerius J., Gummert JF, Borger MA, et al. Stroke after cardiac surgery: a risk factor analysis of 16,184 consecutive adult patients. Ann Thorac Surg 2003; 75: 472-478.
14. Hogue CW Jr., Murphy SF, Schechtman KB, Dávila-Román VG Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999; 100: 642-647.